BackENDRA Life Sciences- Warrants (12/05/2022) Overview

ENDRA Life Sciences- Warrants (12/05/2022) EBIT

EBIT (Earnings Before Interest and Taxes) analysis for NDRAW.

Quarterly EBIT

$0.00

As of Mar 31, 2026

Annual EBIT (TTM)

-$1.60M
81.95% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)